- Investing Ideas
- /
- Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
Square Pharmaceuticals
Market Cap: ৳204.5b
Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳230.70
7D
2.4%
1Y
0.3%
Renata
Market Cap: ৳58.0b
Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.
RENATA
৳505.80
7D
-1.2%
1Y
-34.0%
Beximco Pharmaceuticals
Market Cap: ৳52.7b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳118.10
7D
9.7%
1Y
19.2%